Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Benitec Biopharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Benitec Biopharma Acquires Rights to Hepbarna from Biomics 13
Partnerships 14
Axovant Sciences Enters into Research Partnership with Benitec Biopharma 14
Benitec Biopharma to Enter into Research Agreement with NantVentures 15
ReNeuron Enters into Research Agreement with Benitec Biopharma 16
Benitec Biopharma Enters Into An Agreement With Stanford University 17
Licensing Agreements 18
Axovant Sciences Enters into Licensing Agreement with Benitec Biopharma 18
Benitec Biopharma Enters into Licensing Agreement with Nant Capital 19
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 20
Benitec Biopharma Enters into Option for License Agreement with Touchlight Genetics for doggybone DNA 21
Benitec Biopharma Enters into Licensing Agreement with Circuit Therapeutics 22
Benitec Biopharma Enters Into Licensing Agreement With Regen BioPharma For ddRNAi Gene Silencing Technology 23
Benitec Biopharma Enters Into Licenising Agreement With uniQure 25
Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies 26
Benitec Enters Into Licensing Agreement With Calimmune For ddRNAi Technology 27
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 28
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 29
Equity Offering 30
Benitec Biopharma Raises USD4.7 Million in Rights Offering of Shares 30
Benitec Biopharma to Raise USD2 Million in Private Placement of American Depositary Shares 31
Benitec Biopharma Raises USD4.11 million in Private Placement of Shares 32
Benitec Biopharma Raises USD13.8 Million in Public Offering of ADS 33
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$28 Million 35
Benitec Biopharma Completes Rights Offering Of Shares For US$2.7 Million 37
Benitec Biopharma Completes Private Placement Of Shares For US$7 Million 38
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$7.2 Million 39
Benitec Biopharma Completes Private Placement Of Shares For US$0.2 Million 41
Benitec Biopharma Completes Private Placement Of Shares For US$0.8 Million 42
Acquisition 43
Benitec Biopharma Completes Acquisition Of Tacere Therapeutics For Up To US$1.2 Million 43
Benitec Biopharma Ltd – Key Competitors 44
Benitec Biopharma Ltd – Key Employees 45
Benitec Biopharma Ltd – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Financial Announcements 47
May 31, 2018: Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update 47
May 31, 2018: Benitec Biopharma: Interim Report for the nine months ended March 31, 2018 49
Feb 22, 2018: Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update 50
Nov 29, 2017: Benitec Biopharma reports financial results for the 2018 fiscal first quarter and provides operational update 52
May 30, 2017: Benitec Biopharma : Interim Report for the nine months ended March 31, 2017 54
Corporate Communications 55
Sep 19, 2018: Benitec Biopharma names Gregory R. Reyes as senior scientific advisor 55
Oct 23, 2017: Benitec announces resignation of Director, Dr John Chiplin 56
Oct 12, 2017: Benitec announces the appointment of a new Chairman 57
Oct 10, 2017: Benitec announces resignation of Chief Business and Operations Officer 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Benitec Biopharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Benitec Biopharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Benitec Biopharma Acquires Rights to Hepbarna from Biomics 13
Axovant Sciences Enters into Research Partnership with Benitec Biopharma 14
Benitec Biopharma to Enter into Research Agreement with NantVentures 15
ReNeuron Enters into Research Agreement with Benitec Biopharma 16
Benitec Biopharma Enters Into An Agreement With Stanford University 17
Axovant Sciences Enters into Licensing Agreement with Benitec Biopharma 18
Benitec Biopharma Enters into Licensing Agreement with Nant Capital 19
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 20
Benitec Biopharma Enters into Option for License Agreement with Touchlight Genetics for doggybone DNA 21
Benitec Biopharma Enters into Licensing Agreement with Circuit Therapeutics 22
Benitec Biopharma Enters Into Licensing Agreement With Regen BioPharma For ddRNAi Gene Silencing Technology 23
Benitec Biopharma Enters Into Licenising Agreement With uniQure 25
Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies 26
Benitec Enters Into Licensing Agreement With Calimmune For ddRNAi Technology 27
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 28
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 29
Benitec Biopharma Raises USD4.7 Million in Rights Offering of Shares 30
Benitec Biopharma to Raise USD2 Million in Private Placement of American Depositary Shares 31
Benitec Biopharma Raises USD4.11 million in Private Placement of Shares 32
Benitec Biopharma Raises USD13.8 Million in Public Offering of ADS 33
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$28 Million 35
Benitec Biopharma Completes Rights Offering Of Shares For US$2.7 Million 37
Benitec Biopharma Completes Private Placement Of Shares For US$7 Million 38
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$7.2 Million 39
Benitec Biopharma Completes Private Placement Of Shares For US$0.2 Million 41
Benitec Biopharma Completes Private Placement Of Shares For US$0.8 Million 42
Benitec Biopharma Completes Acquisition Of Tacere Therapeutics For Up To US$1.2 Million 43
Benitec Biopharma Ltd, Key Competitors 44
Benitec Biopharma Ltd, Key Employees 45
Benitec Biopharma Ltd, Other Locations 46
Benitec Biopharma Ltd, Subsidiaries 46
List of Figures
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Benitec Biopharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10